What if tumors could be treated with pinpoint accuracy, sparing healthy tissue and reducing treatment times? At UCI Health, our radiation oncology team leverages cutting-edge techniques like stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) to do just that. These noninvasive treatments target even the smallest, hardest-to-reach tumors with sub-millimeter precision.

Patients experience fewer side effects and faster recoveries with high-dose precision and shorter treatment durations. Here, Jeremy Harris, MD, explains the science and coordination behind SRS and its impact on cancer care.

Related Presenters

Jeremy Harris, MD

Radiation Oncology

Clinical Interests central nervous system cancers, head and neck cancer, lung cancer, soft tissue sarcomas, stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS)

View full profile